Prime Medicine, Inc. Operating CF/Net income

Operating CF/Net income of PRME for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating CF/Net income growth rates and interactive chart. Calculated as operating cash flow divided by net income to common shareholders. Also called income quality ratio. A ratio of greater than 1.0 usually indicates high-quality income, while a ratio of less than 1.0 indicates low-quality.

Highlights and Quick Summary

  • Operating CF/Net income for the quarter ending September 30, 2023 was 0.77 (a -19.8% decrease compared to previous quarter)
  • Year-over-year quarterly Operating CF/Net income increased by 2.1%
  • Annual Operating CF/Net income for 2022 was 0.93 (a 401.51% increase from previous year)
  • Annual Operating CF/Net income for 2021 was 0.19 (a -83.12% decrease from previous year)
  • Annual Operating CF/Net income for 2020 was 1.1 (a 129.68% increase from previous year)
  • Twelve month Operating CF/Net income ending September 30, 2023 was 0.88 (a -2.88% decrease compared to previous quarter)
  • Twelve month trailing Operating CF/Net income decreased by -5.24% year-over-year
Trailing Operating CF/Net income for the last four month:
30 Sep '23 30 Jun '23 31 Mar '23 31 Dec '22
0.88 0.91 0.81 0.93
Visit stockrow.com/PRME for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating CF/Net income of Prime Medicine, Inc.

Most recent Operating CF/Net incomeof PRME including historical data for past 10 years.

Interactive Chart of Operating CF/Net income of Prime Medicine, Inc.

Prime Medicine, Inc. Operating CF/Net income for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 0.77 0.96 1.05 – –
2022 0.76 0.84 0.57 1.69 0.93
2021 – – 0.0 0.92 0.19
2020 – – – 0.0 1.1
2019 – – – – 0.48

Business Profile of Prime Medicine, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com